Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. SMTI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
SMTI stock price ended at $31.51 on Friday, after rising2.04%
The Sanara Medtech Inc stock price increased by 2.04% on the last trading day (16 May 2025), rising from 31.44 to 31.51. Throughout the last trading session, the stock experienced a fluctuation of 0.87% , ranging from a day low of $31.17 to a day high of 31.44. The price has declined in 6 of the last 10 days, resulting in a total change of -4.20% during this period. On the last day, trading volume increase by -63.90K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 16.42K shares were traded, amounting to approximately 513.36K.
SMTI Technical Signals
SMTI(Sanara Medtech Inc Corp) has 3 buy signals and 3 sell signals now. The current trend is consolidation starting from 2025-05-13. The total price change during this trend is -13.21%. Recently, the price has increased significantly with an increase in volume, indicating a strong bullish signal. The average turnover of SMTI over the last 5 trading days is 1.32M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
SMTI Moving Average Analysis
Sanara Medtech Inc's overall moving average trend leans more bearish as of Saturday, May 17, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $35.978363333333334, and $37.920833333333334. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $29.693303333333336, and $27.750833333333336. A break-down below any of these levels will issue sell signals.
SMTI Short Selling Analysis
The short sale ratio of Sanara Medtech Inc(SMTI) as of 12 May 2025 is 18.86%, dropping from last trading day. With decreasing price from 32.35 to 34.37. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Sell
3
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
2.278
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.421
Bullish
Williams %R (14 days)
WILLR_14 < -80
-100
Bullish
3 Bearish Signals
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 < 0
-1.775
Bearish
Closing price
close < fibonacci_S1
30.465
Bearish
Moving Average
5-day SMA crosses below 200-day SMA
--
Bearish
SMTI Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Sanara Medtech Inc(SMTI), our algorithm predicts SMTI's 1-month price at $33.83, with an 4.59%upwardshift. Using a similarity score up to 96.93%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Sanara Medtech Inc (SMTI.O) stock, as of Sunday, May 11, 2025 , forecasts a 4.59% change over the next month, based on its high correlation with HR.N stock patterns. The similarity between their price movements over the analyzed periods is 96.93%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
SMTI
No Data
HR
Up: 4.59%Similarity: 96.93%
Name
Similarity
Up/Down
HR.N
96.93%
+4.59%
MSA.N
96.92%
+1.22%
CINF.O
96.76%
+1.75%
EFX.N
96.61%
+3.25%
CRS.N
96.59%
+9.21%
AKR.N
96.49%
-2.01%
PNR.N
96.47%
+8.15%
ALLE.N
96.43%
+2.67%
SEMR.N
96.39%
+3.85%
BASE.O
96.26%
+5.63%
SMTI Seasonality Analysis
Based on SMTI's historical stock price data across all years, the probability of a positive return in May is45.45%, suggesting it maynotbe an ideal month to invest in SMTI. In contrast,Julyoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Sanara Medtech Inc (SMTI.O) stock in July has the highest probability of a positive return (80.00%), while September has the lowest probability (30.00%).
Performance Seasonality
The chart shows Sanara Medtech Inc. (SMTI)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Sanara Medtech Inc (SMTI.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. SMTI has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Sanara Medtech Inc (SMTI.O) stock in a year?
The radar chart shows that buying Sanara Medtech Inc (SMTI.O) stock in July has the highest probability of a positive return (80.00%), while September has the lowest probability (30.00%).
How has Sanara Medtech Inc. (SMTI)'s stock price performed over the past three years?
SMTI's stock price rose by 1.48% in 2023,decreased by -18.91% in 2024, and went down by 4.8% in 2025.
Bearish technical signals of SMTI include: MOM_10 < 0, close < fibonacci_S1, 5-day SMA crosses below 200-day SMA.
Is SMTI a buy based on overall technical signals summary?
SMTI has 3 buy signals and 3 sell signals now. Overall the technical rating for SMTI is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of SMTI.
What is the trend of Sanara Medtech Inc (SMTI)'s moving average?
Sanara Medtech Inc's overall moving average trend leans more bearish as of May 17 2025, with 3 negative signals and 1 positive signal.
What is price prediction for SMTI stock next month?
The price prediction chart for Sanara Medtech Inc (SMTI.O) stock, as of May 11 2025, forecasts a 4.59% change over the next month, based on its high correlation with HR stock patterns. The similarity between their price movements over the analyzed periods is 96.93%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for SMTI Stock?
### **Price Prediction for SMTI Stock in 2025**
Sanara MedTech (SMTI) is expected to reach a price of **$40** by the end of 2025. This prediction is based on strong revenue growth and positive sector trends. However, there is a risk of correction if growth slows or valuations adjust.
What is price prediction 2030 for SMTI Stock?
### **Price Prediction for SMTI Stock in 2030**
Based on current trends and analysis, SMTI stock is predicted to reach **$50 by 2030**. This forecast is supported by the company's strong revenue growth of 35.24% and manageable debt levels, despite current operating losses. Analysts' 12-month price targets suggest confidence in moderate growth, aligning with this projection.